輸入代號或公司名稱後按 Enter
4188

安克

-0.05 (-0.35%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
14.1569成交張數本益比1.74股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入202530年增 -42.7%
毛利率202532.9%最新一期
營業利益率2025-289.0%最新一期
每股盈餘2025-0.88
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計0.0%5.4%31.6%26.1%33.8%29.3%38.3%37.1%38.0%67.1%
營業毛利(毛損)100.0%94.6%68.4%73.9%66.2%70.7%61.7%62.9%62.0%32.9%
營業毛利(毛損)淨額100.0%94.6%68.4%73.9%66.2%70.7%61.7%62.9%62.0%32.9%
推銷費用68.9%67.0%33.6%27.7%25.2%18.1%29.7%32.0%37.1%66.3%
管理費用247.8%124.2%52.3%43.8%51.5%36.2%48.9%46.0%64.2%100.8%
研究發展費用371.3%205.5%93.2%69.4%77.3%59.4%87.6%67.6%82.4%154.8%
營業費用合計688.1%396.8%179.2%140.9%154.2%113.6%166.1%145.6%183.8%321.9%
營業利益(損失)-588.1%-302.2%-110.7%-66.9%-88.0%-42.9%-104.3%-82.7%-121.8%-289.0%
利息收入4.8%3.0%5.1%6.6%9.9%19.0%
其他收入48.1%25.9%53.0%9.9%18.4%6.4%8.5%10.3%12.9%36.9%
其他利益及損失淨額0.7%-0.5%-0.5%0.8%-2.3%2.2%2.8%-0.1%-0.3%-1.3%
財務成本淨額0.2%0.2%0.1%0.2%0.2%0.2%0.3%0.3%
營業外收入及支出合計48.7%25.4%52.3%10.5%20.7%11.5%16.2%16.6%22.2%54.4%
稅前淨利(淨損)-539.4%-276.8%-58.5%-56.5%-67.3%-31.3%-88.2%-66.1%-99.6%-234.6%
所得稅費用(利益)合計0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%-0.0%
繼續營業單位本期淨利(淨損)-539.4%-276.8%-58.5%-56.5%-67.3%-31.3%-88.2%-66.1%-99.6%-234.5%
本期淨利(淨損)-539.4%-276.8%-58.5%-56.5%-67.3%-31.3%-88.2%-66.1%-99.6%-234.5%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-7.3%-7.1%0.4%12.0%-9.3%-1.0%9.6%25.8%
不重分類至損益之項目:-7.1%0.4%12.0%-9.3%-1.0%9.6%25.8%
其他綜合損益(淨額)-7.3%-7.1%0.4%12.0%-9.3%-1.0%9.6%25.8%
本期綜合損益總額-539.4%-276.8%-65.8%-63.6%-66.9%-19.4%-97.5%-67.2%-89.9%-208.8%
母公司業主(淨利∕損)-61.8%-44.9%-55.4%-29.8%-86.8%-69.4%-95.2%-183.1%
非控制權益(淨利∕損)3.3%-11.6%-11.9%-1.6%-1.4%3.3%-4.3%-51.5%
母公司業主(綜合損益)-69.1%-52.0%-55.1%-17.8%-96.1%-70.5%-85.6%-157.3%
非控制權益(綜合損益)3.3%-11.6%-11.9%-1.6%-1.4%3.3%-4.3%-51.5%
基本每股盈餘-11.5%-5.2%-1.2%-0.8%-1.0%-0.6%-1.6%-1.3%-1.7%-2.9%
預期信用減損損失(利益)0.1%0.0%0.2%-0.1%-0.1%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。